Global Flow Cytometry in Oncology Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI10242054

Publication Date:

October 2, 2024

Pages:

111

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Flow Cytometry in Oncology market size was valued at US$ million in 2023. With growing demand in downstream market, the Flow Cytometry in Oncology is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Flow Cytometry in Oncology market. Flow Cytometry in Oncology are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Flow Cytometry in Oncology. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Flow Cytometry in Oncology market.
Among the clinical uses of flow cytometry cancer represents one of the most relevant. Several applications of flow cytometry can currently be applied to the study of cancer, including the detection of tumour cell DNA aneuploidy, the analysis of tumour cell proliferation and the immunophenotyping of leukemias.
Key Features:
The report on Flow Cytometry in Oncology market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Flow Cytometry in Oncology market. It may include historical data, market segmentation by Type (e.g., Assays and Kits, Instruments), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Flow Cytometry in Oncology market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Flow Cytometry in Oncology market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Flow Cytometry in Oncology industry. This include advancements in Flow Cytometry in Oncology technology, Flow Cytometry in Oncology new entrants, Flow Cytometry in Oncology new investment, and other innovations that are shaping the future of Flow Cytometry in Oncology.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Flow Cytometry in Oncology market. It includes factors influencing customer ' purchasing decisions, preferences for Flow Cytometry in Oncology product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Flow Cytometry in Oncology market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Flow Cytometry in Oncology market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Flow Cytometry in Oncology market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Flow Cytometry in Oncology industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Flow Cytometry in Oncology market.
Market Segmentation:
Flow Cytometry in Oncology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Assays and Kits
Instruments
Reagents and Consumables
Software
Segmentation by application
Diagnostic Laboratories
Hospitals and Healthcare Centers
Academic and Research Institutions
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Agilent Technologies, Inc.
Apogee Flow Systems Ltd.
Becton, Dickinson and Company
bioAffinity Technologies, Inc.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation Cytek Biosciences
Cytognos, S.L.
Danaher Corporation
Miltenyi Biotec B.V. and Co. KG
Laboratory Corporation of America Holdings
Luminex Corporation
NeoGenomics Laboratories, Inc.
Sony Corporation
Thermo Fisher Scientific Inc

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Flow Cytometry in Oncology Market Size 2019-2030
2.1.2 Flow Cytometry in Oncology Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Flow Cytometry in Oncology Segment by Type
2.2.1 Assays and Kits
2.2.2 Instruments
2.2.3 Reagents and Consumables
2.2.4 Software
2.3 Flow Cytometry in Oncology Market Size by Type
2.3.1 Flow Cytometry in Oncology Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Flow Cytometry in Oncology Market Size Market Share by Type (2019-2024)
2.4 Flow Cytometry in Oncology Segment by Application
2.4.1 Diagnostic Laboratories
2.4.2 Hospitals and Healthcare Centers
2.4.3 Academic and Research Institutions
2.4.4 Others
2.5 Flow Cytometry in Oncology Market Size by Application
2.5.1 Flow Cytometry in Oncology Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Flow Cytometry in Oncology Market Size Market Share by Application (2019-2024)
3 Flow Cytometry in Oncology Market Size by Player
3.1 Flow Cytometry in Oncology Market Size Market Share by Players
3.1.1 Global Flow Cytometry in Oncology Revenue by Players (2019-2024)
3.1.2 Global Flow Cytometry in Oncology Revenue Market Share by Players (2019-2024)
3.2 Global Flow Cytometry in Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Flow Cytometry in Oncology by Regions
4.1 Flow Cytometry in Oncology Market Size by Regions (2019-2024)
4.2 Americas Flow Cytometry in Oncology Market Size Growth (2019-2024)
4.3 APAC Flow Cytometry in Oncology Market Size Growth (2019-2024)
4.4 Europe Flow Cytometry in Oncology Market Size Growth (2019-2024)
4.5 Middle East & Africa Flow Cytometry in Oncology Market Size Growth (2019-2024)
5 Americas
5.1 Americas Flow Cytometry in Oncology Market Size by Country (2019-2024)
5.2 Americas Flow Cytometry in Oncology Market Size by Type (2019-2024)
5.3 Americas Flow Cytometry in Oncology Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Flow Cytometry in Oncology Market Size by Region (2019-2024)
6.2 APAC Flow Cytometry in Oncology Market Size by Type (2019-2024)
6.3 APAC Flow Cytometry in Oncology Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Flow Cytometry in Oncology by Country (2019-2024)
7.2 Europe Flow Cytometry in Oncology Market Size by Type (2019-2024)
7.3 Europe Flow Cytometry in Oncology Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Flow Cytometry in Oncology by Region (2019-2024)
8.2 Middle East & Africa Flow Cytometry in Oncology Market Size by Type (2019-2024)
8.3 Middle East & Africa Flow Cytometry in Oncology Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Flow Cytometry in Oncology Market Forecast
10.1 Global Flow Cytometry in Oncology Forecast by Regions (2025-2030)
10.1.1 Global Flow Cytometry in Oncology Forecast by Regions (2025-2030)
10.1.2 Americas Flow Cytometry in Oncology Forecast
10.1.3 APAC Flow Cytometry in Oncology Forecast
10.1.4 Europe Flow Cytometry in Oncology Forecast
10.1.5 Middle East & Africa Flow Cytometry in Oncology Forecast
10.2 Americas Flow Cytometry in Oncology Forecast by Country (2025-2030)
10.2.1 United States Flow Cytometry in Oncology Market Forecast
10.2.2 Canada Flow Cytometry in Oncology Market Forecast
10.2.3 Mexico Flow Cytometry in Oncology Market Forecast
10.2.4 Brazil Flow Cytometry in Oncology Market Forecast
10.3 APAC Flow Cytometry in Oncology Forecast by Region (2025-2030)
10.3.1 China Flow Cytometry in Oncology Market Forecast
10.3.2 Japan Flow Cytometry in Oncology Market Forecast
10.3.3 Korea Flow Cytometry in Oncology Market Forecast
10.3.4 Southeast Asia Flow Cytometry in Oncology Market Forecast
10.3.5 India Flow Cytometry in Oncology Market Forecast
10.3.6 Australia Flow Cytometry in Oncology Market Forecast
10.4 Europe Flow Cytometry in Oncology Forecast by Country (2025-2030)
10.4.1 Germany Flow Cytometry in Oncology Market Forecast
10.4.2 France Flow Cytometry in Oncology Market Forecast
10.4.3 UK Flow Cytometry in Oncology Market Forecast
10.4.4 Italy Flow Cytometry in Oncology Market Forecast
10.4.5 Russia Flow Cytometry in Oncology Market Forecast
10.5 Middle East & Africa Flow Cytometry in Oncology Forecast by Region (2025-2030)
10.5.1 Egypt Flow Cytometry in Oncology Market Forecast
10.5.2 South Africa Flow Cytometry in Oncology Market Forecast
10.5.3 Israel Flow Cytometry in Oncology Market Forecast
10.5.4 Turkey Flow Cytometry in Oncology Market Forecast
10.5.5 GCC Countries Flow Cytometry in Oncology Market Forecast
10.6 Global Flow Cytometry in Oncology Forecast by Type (2025-2030)
10.7 Global Flow Cytometry in Oncology Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Agilent Technologies, Inc.
11.1.1 Agilent Technologies, Inc. Company Information
11.1.2 Agilent Technologies, Inc. Flow Cytometry in Oncology Product Offered
11.1.3 Agilent Technologies, Inc. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Agilent Technologies, Inc. Main Business Overview
11.1.5 Agilent Technologies, Inc. Latest Developments
11.2 Apogee Flow Systems Ltd.
11.2.1 Apogee Flow Systems Ltd. Company Information
11.2.2 Apogee Flow Systems Ltd. Flow Cytometry in Oncology Product Offered
11.2.3 Apogee Flow Systems Ltd. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Apogee Flow Systems Ltd. Main Business Overview
11.2.5 Apogee Flow Systems Ltd. Latest Developments
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Information
11.3.2 Becton, Dickinson and Company Flow Cytometry in Oncology Product Offered
11.3.3 Becton, Dickinson and Company Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Becton, Dickinson and Company Main Business Overview
11.3.5 Becton, Dickinson and Company Latest Developments
11.4 bioAffinity Technologies, Inc.
11.4.1 bioAffinity Technologies, Inc. Company Information
11.4.2 bioAffinity Technologies, Inc. Flow Cytometry in Oncology Product Offered
11.4.3 bioAffinity Technologies, Inc. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 bioAffinity Technologies, Inc. Main Business Overview
11.4.5 bioAffinity Technologies, Inc. Latest Developments
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Bio-Rad Laboratories, Inc. Company Information
11.5.2 Bio-Rad Laboratories, Inc. Flow Cytometry in Oncology Product Offered
11.5.3 Bio-Rad Laboratories, Inc. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Bio-Rad Laboratories, Inc. Main Business Overview
11.5.5 Bio-Rad Laboratories, Inc. Latest Developments
11.6 Bio-Techne Corporation Cytek Biosciences
11.6.1 Bio-Techne Corporation Cytek Biosciences Company Information
11.6.2 Bio-Techne Corporation Cytek Biosciences Flow Cytometry in Oncology Product Offered
11.6.3 Bio-Techne Corporation Cytek Biosciences Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bio-Techne Corporation Cytek Biosciences Main Business Overview
11.6.5 Bio-Techne Corporation Cytek Biosciences Latest Developments
11.7 Cytognos, S.L.
11.7.1 Cytognos, S.L. Company Information
11.7.2 Cytognos, S.L. Flow Cytometry in Oncology Product Offered
11.7.3 Cytognos, S.L. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Cytognos, S.L. Main Business Overview
11.7.5 Cytognos, S.L. Latest Developments
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Information
11.8.2 Danaher Corporation Flow Cytometry in Oncology Product Offered
11.8.3 Danaher Corporation Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Danaher Corporation Main Business Overview
11.8.5 Danaher Corporation Latest Developments
11.9 Miltenyi Biotec B.V. and Co. KG
11.9.1 Miltenyi Biotec B.V. and Co. KG Company Information
11.9.2 Miltenyi Biotec B.V. and Co. KG Flow Cytometry in Oncology Product Offered
11.9.3 Miltenyi Biotec B.V. and Co. KG Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Miltenyi Biotec B.V. and Co. KG Main Business Overview
11.9.5 Miltenyi Biotec B.V. and Co. KG Latest Developments
11.10 Laboratory Corporation of America Holdings
11.10.1 Laboratory Corporation of America Holdings Company Information
11.10.2 Laboratory Corporation of America Holdings Flow Cytometry in Oncology Product Offered
11.10.3 Laboratory Corporation of America Holdings Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Laboratory Corporation of America Holdings Main Business Overview
11.10.5 Laboratory Corporation of America Holdings Latest Developments
11.11 Luminex Corporation
11.11.1 Luminex Corporation Company Information
11.11.2 Luminex Corporation Flow Cytometry in Oncology Product Offered
11.11.3 Luminex Corporation Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Luminex Corporation Main Business Overview
11.11.5 Luminex Corporation Latest Developments
11.12 NeoGenomics Laboratories, Inc.
11.12.1 NeoGenomics Laboratories, Inc. Company Information
11.12.2 NeoGenomics Laboratories, Inc. Flow Cytometry in Oncology Product Offered
11.12.3 NeoGenomics Laboratories, Inc. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 NeoGenomics Laboratories, Inc. Main Business Overview
11.12.5 NeoGenomics Laboratories, Inc. Latest Developments
11.13 Sony Corporation
11.13.1 Sony Corporation Company Information
11.13.2 Sony Corporation Flow Cytometry in Oncology Product Offered
11.13.3 Sony Corporation Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Sony Corporation Main Business Overview
11.13.5 Sony Corporation Latest Developments
11.14 Thermo Fisher Scientific Inc
11.14.1 Thermo Fisher Scientific Inc Company Information
11.14.2 Thermo Fisher Scientific Inc Flow Cytometry in Oncology Product Offered
11.14.3 Thermo Fisher Scientific Inc Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Thermo Fisher Scientific Inc Main Business Overview
11.14.5 Thermo Fisher Scientific Inc Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂